Imaging Agent
Showing 1 - 25 of >10,000
Metastatic Cancer, Unresectable Malignant Tumor Trial in Groningen (Anti-CD8 PET imaging agent)
Recruiting
- Metastatic Cancer
- Unresectable Malignant Neoplasm
- Anti-CD8 PET imaging agent
-
Groningen, NetherlandsUniversity Medical Center Groningen
Mar 1, 2022
Prostate Cancer Trial in Bala-Cynwyd (rhPSMA-7.3 (18F))
Not yet recruiting
- Prostate Cancer
- rhPSMA-7.3 (18F)
-
Bala-Cynwyd, PennsylvaniaMidLantic Urology
Mar 22, 2023
Marginal Zone Lymphoma Trial ([68Ga]Ga-PentixaFor, [18F]Fluorodeoxyglucose)
Not yet recruiting
- Marginal Zone Lymphoma
- (no location specified)
Nov 6, 2023
Lung Cancer, Lung Metastases Trial in Orlando (VGT-309)
Recruiting
- Lung Cancer
- Lung Metastases
-
Orlando, FloridaOrlando Health Cancer Institute
Nov 22, 2023
Metastatic Cancer, Carcinoma, Adenocarcinoma Trial in Cleveland (18F-Clofarabine)
Recruiting
- Metastatic Cancer
- +2 more
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
May 11, 2022
Extramedullary Myeloma Trial in Melbourne (Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent)
Not yet recruiting
- Extramedullary Myeloma
- Combination Product: JNJ-68284528 (Cilta-cel) & 64Cu SPION dual PET-MR imaging agent
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Dec 18, 2022
Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Nashville (biological, other,
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Recurrent Head and Neck Squamous Cell Carcinoma
- Panitumumab
- +9 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Jun 4, 2023
Prostate Carcinoma Trial in Philadelphia (Perflutren Lipid Microspheres, Ultrasound)
Recruiting
- Prostate Carcinoma
- Perflutren Lipid Microspheres
- Ultrasound
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jun 17, 2022
Amyotrophic Lateral Sclerosis (ALS) Trial in Stanford (18F-OP-801)
Not yet recruiting
- Amyotrophic Lateral Sclerosis (ALS)
-
Stanford, CaliforniaStanford University
May 25, 2022
Healthy Volunteers Trial in New York (Hyperpolarized [13C] Pyruvate)
Enrolling by invitation
- Healthy Volunteers
- Hyperpolarized [13C] Pyruvate
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 7, 2022
Ischemic Heart Disease (IHD) Trial in Tianjin (XTR003)
Completed
- Ischemic Heart Disease (IHD)
-
Tianjin, Tianjin, ChinaTEDA International Cardiovascular Hospital
May 23, 2023
Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor Grade 1 Trial ([203Pb]VMT-a-NET, SPECT/CT)
Enrolling by invitation
- Neuroendocrine Tumor Grade 2
- Neuroendocrine Tumor Grade 1
- [203Pb]VMT-α-NET
- SPECT/CT
-
Iowa City, IowaThe University of Iowa
Dec 9, 2022
Prostate Cancer, Recurrent Prostate Cancer Trial in Tampa (F-DCFPyL Injection, PSMA PET)
Recruiting
- Prostate Cancer
- Recurrent Prostate Cancer
- F-DCFPyL Injection
- PSMA PET
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 24, 2023
Recurrent Plasma Cell Myeloma, Plasma Cell Myeloma, Secondary Amyloidosis Trial in Duarte (biological, drug, procedure, other)
Active, not recruiting
- Recurrent Plasma Cell Myeloma
- +2 more
- Daratumumab
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 22, 2022
Colonic Dysplasia, Adenomatous Polyps, Irritable Bowel Disease Trial in Ann Arbor (confocal endomicroscope, Fluorescein)
Recruiting
- Colonic Dysplasia
- +2 more
- confocal endomicroscope
- Fluorescein
-
Ann Arbor, MichiganUniversity of Michigan
Dec 6, 2021
Transthyretin Amyloidosis Trial in New York (I 124-Evuzamitide)
Recruiting
- Transthyretin Amyloidosis
- I 124-Evuzamitide
-
New York, New YorkColumbia University Irving Medical Center
Nov 23, 2022
Solid Tumor Trial in Suzhou (68Ga-NODAGA-SNA006)
Recruiting
- Solid Tumor
- 68Ga-NODAGA-SNA006
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Jul 8, 2022
Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in San Francisco (drug, biological, procedure)
Recruiting
- Prostate Cancer
- Metastatic Castration-resistant Prostate Cancer
- 89Zr-DFO-YS5
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 29, 2022
Lung Cancer Trial in Philadelphia (VGT-309)
Recruiting
- Lung Cancer
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Nov 29, 2022
An Imaging Agent With Positron Emission Tomography/Magnetic
Recruiting
- Recurrent Soft Tissue Sarcoma
- +2 more
- Fluorodopa F 18
- +4 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 4, 2023
Brain Tumor Trial in Stanford (Panitumumab-IRDye800, Pinpoint-IR9000 endoscopic/handheld device, Explorer Air camera)
Not yet recruiting
- Brain Tumor
- Panitumumab-IRDye800
- +3 more
-
Stanford, CaliforniaStanford Cancer Center
Nov 9, 2022
Head Neck Cancer, Unknown Primary Cancer, Head and Neck Squamous Cell Carcinoma Trial in Dallas (Pegsitacianine)
Not yet recruiting
- Head and Neck Cancer
- +2 more
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Jan 18, 2023